Clinical Trials Browser

Completed × treosulfan × Myeloid × Clear all

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00796068 2023-02-17

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00822393 2020-07-30

Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)

Phase 3 Completed

570 enrolled 3 FDA

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02333058 2020-05-04

Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies

Phase 2 Completed

70 enrolled

Myeloid

Myelodysplastic Syndromes

NCT01772953 2016-10-12

Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT

Phase 2 Completed

40 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00491634 2015-12-02

Treosulfan-based Conditioning for Transplantation in AML/MDS

Phase 2 Completed

24 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00253513 2012-06-01

Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

Phase 1/2 Completed

60 enrolled 15 charts

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01062490 2010-02-04

Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)

Phase 2 Completed

45 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes

Clinical Trials

FLAT-Auto

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant

Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)

Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies

Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT

Treosulfan-based Conditioning for Transplantation in AML/MDS

Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)